Northeast Financial Consultants Inc - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 334 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
Northeast Financial Consultants Inc ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$276,860
-5.3%
7,7400.0%0.02%
-10.0%
Q4 2022$292,340
-14.5%
7,7400.0%0.02%
-20.0%
Q3 2022$342,000
+19.2%
7,7400.0%0.02%
+25.0%
Q2 2022$287,0000.0%7,7400.0%0.02%
+17.6%
Q1 2022$287,000
+21.6%
7,7400.0%0.02%
+21.4%
Q4 2021$236,000
-9.2%
7,7400.0%0.01%
-17.6%
Q3 2021$260,000
-15.9%
7,7400.0%0.02%
-19.0%
Q2 2021$309,000
-11.2%
7,7400.0%0.02%
-22.2%
Q1 2021$348,000
-20.5%
7,7400.0%0.03%
-25.0%
Q4 2020$438,000
+19.3%
7,7400.0%0.04%
+9.1%
Q3 2020$367,000
-19.5%
7,7400.0%0.03%
-25.0%
Q2 2020$456,000
+24.6%
7,7400.0%0.04%
+7.3%
Q1 2020$366,000
-21.8%
7,7400.0%0.04%
-2.4%
Q4 2019$468,000
-2.3%
7,740
-3.2%
0.04%
-14.3%
Q3 2019$479,000
-6.8%
8,0000.0%0.05%
-7.5%
Q2 2019$514,000
-20.4%
8,000
+0.5%
0.05%
-26.4%
Q1 2019$646,000
+101.9%
7,963
+3.4%
0.07%
-27.3%
Q2 2018$320,000
-5.6%
7,7030.0%0.10%
-13.2%
Q1 2018$339,000
-12.4%
7,7030.0%0.11%
-11.6%
Q4 2017$387,000
-1.0%
7,7030.0%0.13%
-9.8%
Q3 2017$391,000
-0.3%
7,7030.0%0.14%
-7.1%
Q2 2017$392,000
+26.5%
7,7030.0%0.15%
+19.4%
Q1 2017$310,000
-15.8%
7,7030.0%0.13%
-21.3%
Q4 2016$368,000
+30.5%
7,7030.0%0.16%
+37.8%
Q3 2016$282,0007,7030.12%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,541,046$126,5576.89%
M28 Capital Management LP 126,300$4,513,9625.10%
Bellevue Group AG 9,511,900$339,955,3064.93%
Deep Track Capital, LP 2,834,069$101,289,6264.16%
BVF INC/IL 2,560,761$91,521,5983.35%
Sicart Associates LLC 210,698$7,530,3472.93%
Privium Fund Management B.V. 182,773$6,532,3072.19%
Camber Capital Management LP 1,925,000$68,8002.12%
Orbimed Advisors 2,124,500$75,929,6301.49%
SECTOR GAMMA AS 146,441$5,233,8011.27%
View complete list of IONIS PHARMACEUTICALS INC shareholders